Variable adoption of intrapleural fibrinolytic therapy for pleural space infections

A. Jackson (Seattle, United States of America), J. Rayburn (Seattle, United States of America), C. Fuller (Seattle, United States of America), C. Wilshire (Seattle, United States of America), C. Gilbert (Seattle, United States of America), B. Louie (Seattle, United States of America), R. Aye (Seattle, United States of America), E. Vallières (Seattle, United States of America), A. Farivar (Seattle, United States of America), A. Bograd (Seattle, United States of America), K. Costas (Everett, United States of America), J. Handy (Portland, United States of America), S. Kotova (Portland , United States of America), J. Gorden (Seattle, United States of America)

Source: International Congress 2018 – Pleural interventions
Session: Pleural interventions
Session type: Thematic Poster
Number: 891
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Jackson (Seattle, United States of America), J. Rayburn (Seattle, United States of America), C. Fuller (Seattle, United States of America), C. Wilshire (Seattle, United States of America), C. Gilbert (Seattle, United States of America), B. Louie (Seattle, United States of America), R. Aye (Seattle, United States of America), E. Vallières (Seattle, United States of America), A. Farivar (Seattle, United States of America), A. Bograd (Seattle, United States of America), K. Costas (Everett, United States of America), J. Handy (Portland, United States of America), S. Kotova (Portland , United States of America), J. Gorden (Seattle, United States of America). Variable adoption of intrapleural fibrinolytic therapy for pleural space infections. 891

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The effect of intrapleural fibrinolytic therapy in the drainage of loculated haemorrhagic effusions
Source: Eur Respir J 2001; 18: Suppl. 33, 387s
Year: 2001

An international survey on the use of intrapleural tissue plasminogen activator/DNase therapy for pleural infection
Source: ERJ Open Res, 8 (1) 00590-2021; 10.1183/23120541.00590-2021
Year: 2022



Intrapleural streptokinase in the management of loculated pleural fluids of various aetiologies
Source: Annual Congress 2010 - 100 years of thoracoscopy: still room for improvement?
Year: 2010

Intrapleural fibrinolytic treatment of empyemas
Source: Eur Respir J 2005; 26: Suppl. 49, 491s
Year: 2005

Efficacy of intrapleural streptokinase use in complicated parapneumonic pleural effusions and empyema
Source: Annual Congress 2008 - Pleural effusion
Year: 2008


Respiratory functional status after intrapleural t-PA administration for complicated parapneumonic effusions
Source: Annual Congress 2012 - Viral infections and rare respiratory infections
Year: 2012

Malignant pleural effusion: treatment of the fluid and intrapleural therapy
Source: ERS Online Course 2020: Calendar sheets in malignant pleural diseases
Year: 2020

Intrapleural perfusion hyperthermo-chemotherapy for malignant pleural effusion
Source: Annual Congress 2009 - Preoperative functional assessment and surgery for malignant diseases
Year: 2009

Intrapleural fibrinolysis modulation in malignant pleural effusions
Source: Eur Respir J 2001; 18: Suppl. 33, 517s
Year: 2001

Primary thoracoscopy versus fibrinolysis in the management of pleural sepsis
Source: Eur Respir J 2004; 24: Suppl. 48, 51s
Year: 2004

A clinical comparison of intrapleural heparin versus urokinase in the management of tuberculous pleurisy
Source: Eur Respir J 2005; 26: Suppl. 49, 647s
Year: 2005

Intrapleural tPA increases pleural fluid output in pleural infection, independent of chest X-ray opacification
Source: International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management
Year: 2015

Safety and efficacy of reduced dose intrapleural alteplase and DNAase for pleural infection
Source: International Congress 2018 – Difficult-to-treat respiratory infections
Year: 2018

Effectiveness and safety of tunneled pleural catheter placement in patients with malignant pleural effusions
Source: International Congress 2019 – Interventional pulmonology: current pleural practice
Year: 2019


Intrapleural urokinase in the management of empyema in children
Source: Eur Respir J 2004; 24: Suppl. 48, 620s
Year: 2004

Efficacy and complications of small-bore catheters in the management of malignant pleural effusions
Source: Eur Respir J 2007; 30: Suppl. 51, 103s
Year: 2007

Intrapleural tenectaplase therapy in treatment of loculated parapneumonic pleural effusions and empyema
Source: International Congress 2015 – Clinical issues in CAP: microbiological and radiological determinants
Year: 2015

Intrapleural fibrinolytic treatment with streptokinase for empyema during pregnancy: 2 cases
Source: Annual Congress 2010 - Infections and pleural problems
Year: 2010


Role of pleural irrigation with normal saline versus streptokinase in complicated pleural effusions.
Source: International Congress 2019 – Interventional pulmonology: current pleural practice
Year: 2019


Management of malignant pleural effusion in recurrent SCLC by intrapleural gene therapy
Source: Eur Respir J 2003; 22: Suppl. 45, 61s
Year: 2003